Data Curation and Entry in DIDB – November Summary

In November, we added 142 citations in DIDB, including 41 in vitro (with 25 articles published in Nov 2021) and 101 in vivo articles (with 40 articles published in Nov 2021).

Five approved NDAs/BLA were also added, with the 3 following NDAs: atogepant (QULIPTA), difelikefalin (KORSUVA), mobocertinib (EXKIVITY), and 2 BLAs: lonapegsomatropin (SKYTROFA), tisotumab vedotin (TIVDAK)

You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.

As always, feel free to contact us if you have any questions or comments.